Global Dashboard for Vaccine Equity
COVID-19 vaccine inequity will have a lasting and profound impact on socio-economic recovery in low- and lower-middle income countries without urgent action to boost supply, share vaccines and ensure they’re accessible to everyone now.
The Global Dashboard for Vaccine Equity combines the latest data on the global roll-out of COVID-19 vaccines with the most recent socio-economic information to illustrate why accelerating vaccine equity is not only critical to saving lives but also to driving a faster and fairer recovery from the pandemic with benefits for all.
It provides new, actionable insights and possibilities for policy makers to dive into the implications of vaccine inequity for socio-economic recovery, jobs and welfare. Analyses can be generated and compared by country, region and globally, and organised per income group.
The Dashboard is a joint initiative of UNDP, WHO and the University of Oxford with cooperation across the UN system, anchored in the SDG 3 Global Action Plan for Healthy Lives and Well-being for All.
What is vaccine equity?
Vaccine equity means that vaccines should be allocated equally across all countries, regardless of their developmental or economic status. Access to and allocation of vaccines should be based on principles grounded in the right of every human to enjoy the highest attainable standard of health without distinction of race, religion, political belief, economic, or any other social condition.
Globally, the distribution of vaccines is shaped by challenging political, economic, social, diplomatic, and health-related matters. Therefore, accurate and up-to-date data and information are critical components in guiding the international community’s understanding of vaccine equity and shed light on the blind spots essential for achieving the last mile on vaccine equity.
How accessible are vaccines globally?
A slower and delayed vaccination rollout in low and middle-income countries has left them vulnerable to COVID-19 variants, new surges of the virus and a slower recovery out of the crisis. High-income countries started vaccination on average two months earlier than low-income countries and access to vaccines in low-income countries is still strikingly low.
The almost invisible red line at the bottom of the graph is a stark reminder of the gap between rich and poor countries.
Are vaccines affordable for all countries?
Data from UNICEF and Gavi, the Vaccine Alliance, shows that the average cost per COVID-19 vaccine dose ranges between US$ 2 – $ 40. The estimated distribution cost is US$ 3.70 per person vaccinated with two doses, after accounting for vaccine wastage.
This represents a significant financial burden for low-income countries, where the average annual per capita health expenditure amounts to US$ 41. While vaccination programmes will increase healthcare costs across all countries, it is especially the case in low-income countries as they would need to increase their health expenditure by a staggering 30-60 percent to reach seventy percent of their population under the current pricing. High-income countries are expected to increase theirs by only 0.8 percent to achieve the same vaccination rate.
While COVAX provides a global risk sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines, if a greater coverage is required to ensure a stop to the spread of COVID-19, the financial burden on most vulnerable countries increases. Additionally, some countries are already considering booster doses, which indicates that COVID-19 vaccinations may become a recurring expense for countries.
How can vaccines be financed?
Countries need to urgently boost their efforts to achieve the target of fully vaccinating 70 percent of their populations, which means increasing health expenditures and potentially taking up more debt.
Impact of vaccine inequity on economic recovery.
High-income countries have borne the brunt of COVID-19 cases and related deaths. But analysis of the latest projections of global economic growth show greater negative economic impacts in low-income and lower-middle-income countries.